Zentalis Announces Presentation of Positive Phase 1b Data
Strong anti-tumor activity shown in a platinum-resistant ovarian cancer population, with a confirmed ORR of 50.0% and mPFS of 7.4 months in combination...
Source: globenewswire.com
Frequent Grade News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Frequent Grade. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.